Author

Rudolf Walther van Olden

Observed names: R W van Olden, R. W. van Olden, R.W. van Olden, RUDOLF W. VAN OLDEN, Rudolf Van Olden, Rudolf W van Olden, Rudolf W. Van Olden, Rudolf W. van Olden, Rudolf van Olden, van Olden, R.W., van Olden, Rudolf

Observed institutions: Novartis (Switzerland), University of Groningen, Amsterdam UMC Location University of Amsterdam, Dianet, Amsterdam University Medical Centers, GlaxoSmithKline (Netherlands), Novartis Gene Therapies Switzerland GmbH, Novartis Gene Therapies, Inc. (United States), Amsterdam Cardiovascular Sciences, University of Amsterdam

ORCID: 0009-0004-8130-9858

Observed ORCID: 0009-0004-8130-9858

OpenAlex ID: A5062133607

Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis.

1996 · R W van Olden, R T Krediet, et al. · Journal of the American Society of Nephrology · 236

Predicting mortality in intensive care patients with acute renal failure treated with dialysis.

1997 · C E Douma, W K Redekop, et al. · Journal of the American Society of Nephrology · 147

Cardiac and hemodynamic effects of hemodialysis and ultrafiltration

2000 · Willem Jan W. Bos, Sjoerd Bruin, et al. · American Journal of Kidney Diseases · 101

Cytokine Filtration and Adsorption during Pre- and Postdilution Hemofiltration in Four Different Membranes

1998 · Catherine S.C. Bouman, Rudolf W. van Olden, et al. · Blood Purification · 88

Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium

2021 · François Boemer, Jean-Hubert Caberg, et al. · Scientific Reports · 83

PDF

Acute Effects of High-Dose Furosemide on Residual Renal Function in CAPD Patients

2003 · Rudolf W. Van Olden, Henk-Jan Guchelaar, et al. · Peritoneal Dialysis International · 65

Core competencies for pharmaceutical physicians and drug development scientists

2013 · Honorio Silva, Peter Stonier, et al. · Frontiers in Pharmacology · 57

PDF

Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments

1995 · R. W. van Olden, B. A. C. van Acker, et al. · Nephrology Dialysis Transplantation · 54

Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec

2021 · John W. Day, Richard S. Finkel, et al. · Molecular Therapy — Methods & Clinical Development · 49

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands

2022 · Rimma Velikanova, Simon van der Schans, et al. · Value in Health · 43

Acute and Long-Term Effects of Therapy with High-Dose Furosemide in Chronic Hemodialysis Patients

1992 · Rudolf W. van Olden, Joseph J.M. van Meyel, et al. · American Journal of Nephrology · 42

Long‐Term (Subacute) Potassium Treatment in Congenital HERG‐Related Long QT Syndrome (LQTS2)

1999 · HANNO L. TAN, MARCO ALINGS, et al. · Journal of Cardiovascular Electrophysiology · 41

Augmenting solute clearance in peritoneal dialysis

1998 · Raymond T. Krediet, Caroline E. Douma, et al. · Kidney International · 39

Intracellular and extracellular blood magnesium fractions in hemodialysis patients; is the ionized fraction a measure of magnesium excess?

1998 · Henk J Huijgen, Renata Sanders, et al. · Clinical Chemistry · 35

Plasma thrombopoietin levels in patients with chronic renal failure

2002 · Gabor E Linthorst, Claudia C Folman, et al. · The Hematology Journal · 29

Rare diseases' genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project

2023 · Alessandra Ferlini, Edith Sky Gross, et al. · Orphanet Journal of Rare Diseases · 28

PDF

Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe

2023 · Nicolas Garnier, Joanne Berghout, et al. · PLoS ONE · 20

Randomised Long-Term Comparison of Tinzaparin and Dalteparin in Haemodialysis

2003 · Rolinda J.R. Beijering, Hugo ten Cate, et al. · Clinical Drug Investigation · 20

Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency

1995 · R. W. van Olden, J. J. M. van Meyel, et al. · European Journal of Clinical Pharmacology · 19

Practical methods for assessing dialysis efficiency during peritoneal dialysis.

1994 · R T Krediet, G C Koomen, et al. · PubMed · 16

Igg Subclasses in Capd Patients

1996 · Raymond T. Krediet, Ger C.M. Koomen, et al. · Peritoneal Dialysis International · 15

Adeno-associated virus serotype 9 antibody seroprevalence for patients in the United States with spinal muscular atrophy

2023 · John W. Day, Jerry R. Mendell, et al. · Molecular Therapy — Methods & Clinical Development · 14

Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients.

1998 · R W van Olden, B A van Acker, et al. · PubMed · 9

Adeno-associated virus serotype 9 antibodies in neonates and young children: Seroprevalence and kinetics

2024 · Rudolf W. van Olden, Christophe Lo Bianco, et al. · Molecular Therapy — Methods & Clinical Development · 8

Elevated 24-hour blood pressure in peritoneal dialysis patients with ultrafiltration failure.

1998 · W J Bos, D G Struijk, et al. · PubMed · 7

Works count: 41

Citation count: 1,283

H-index: 19

I10-index: 22